Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy

BACKGROUND: New therapies for glioblastoma (GBM) are urgently needed because the disease prognosis is poor. Chimeric antigen receptor (CAR)-T cell therapy that targets GBM-specific cell surface antigens is a promising therapeutic strategy. However, extensive transcriptome analyses have uncovered few...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Tomoyoshi, Kijima, Noriyuki, Hasegawa, Kana, Ikeda, Shunya, Yaga, Moto, Wibowo, Tansri, Tachi, Tetsuro, Kuroda, Hideki, Hirayama, Ryuichi, Okita, Yoshiko, Kinoshita, Manabu, Kagawa, Naoki, Kanemura, Yonehiro, Hosen, Naoki, Kishima, Haruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798403/
https://www.ncbi.nlm.nih.gov/pubmed/36601313
http://dx.doi.org/10.1093/noajnl/vdac177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798403/
https://www.ncbi.nlm.nih.gov/pubmed/36601313
http://dx.doi.org/10.1093/noajnl/vdac177

Ejemplares similares